Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000550584 | SCV000650961 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2025-01-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001584312 | SCV001811755 | likely benign | not provided | 2018-11-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002438464 | SCV002752677 | likely benign | Cardiovascular phenotype | 2019-01-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003486877 | SCV004240634 | benign | Cardiomyopathy | 2023-06-09 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001700413 | SCV001917589 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001584312 | SCV001971781 | likely benign | not provided | no assertion criteria provided | clinical testing |